Home > Insider Trading > Filing (0001181431-13-059233)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
31791	Perkinelmer Inc	PKI	Laboratory Analytical Instruments (3826)	042052042

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1224110	F Robert Friel	940 Winter Street Waltham MA 02451	President And Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2013-11-13	56,230	$23.45	573,079	No	4	M	Direct
Common Stock	Disposition	2013-11-13	56,230	$36.96	516,849	No	4	S	Direct
Common Stock	Acquisiton	2013-11-14	56,231	$23.45	573,080	No	4	M	Direct
Common Stock	Disposition	2013-11-14	56,231	$37.32	516,849	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	NQ Stock Option (right to buy)	Disposition	2013-11-13	56,230	$0.00	56,230	$23.45
Common Stock	NQ Stock Option (right to buy)	Disposition	2013-11-14	56,231	$0.00	56,231	$23.45

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
56,231		2014-01-30	No	4	M	Direct
0		2014-01-30	No	4	M	Direct

Footnotes

The sale reported in this Form 4 was effected pursuant to a 10b5-1 trading plan adopted by Mr. Friel on August 8, 2013.
The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $36.728 to $37.180. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $37.00 to $37.495. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
This option became exercisable in three equal annual installments beginning on January 30, 2008, which was the first anniversary of the date on which the option was granted.